89bio, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 51.68 million compared to USD 28.84 million a year ago. Basic loss per share from continuing operations was USD 0.54 compared to USD 0.54 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.18 USD | -8.40% | -8.81% | -26.77% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.77% | 879M | |
+10.79% | 115B | |
+11.65% | 106B | |
-6.20% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.41% | 17.56B | |
-40.50% | 17.32B | |
+6.64% | 14.03B | |
+31.84% | 12.13B |
- Stock Market
- Equities
- ETNB Stock
- News 89bio, Inc.
- 89bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024